First human tests begin for potential neurological disorder drug
NCT ID NCT05938452
Summary
This early-stage study aims to test the safety of a new capsule called GTB in healthy people. Researchers will give 40 volunteers single and multiple doses to see how their bodies react and process the drug. The main goal is to check for side effects and determine safe dosage levels before testing in patients with neurological conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROLOGICAL DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
TKL Research
Bloomfield, New Jersey, 07003, United States
Conditions
Explore the condition pages connected to this study.